Search for Clinical Trial Results
![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Angioimmunoblastic Lymphadenopathy With Dysproteinemia - 244 Studies Found
Status | Study |
Terminated |
Study Name: Ipilimumab and Local Radiation Therapy in Treating Patients With Recurrent Melanoma, Non-Hodgkin Lymphoma, Colon, or Rectal Cancer Condition:
Interventions: |
Completed |
Study Name: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma Condition:
Interventions: |
Active, not recruiting |
Study Name: Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies Condition:
Interventions: |
Completed |
Study Name: Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies Condition:
Interventions: |
Completed |
Study Name: Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma Condition:
Interventions: |
Terminated |
Study Name: Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant Condition:
Interventions: |
Active, not recruiting |
Study Name: Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma Condition:
Interventions: |
Completed |
Study Name: Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma Condition:
Interventions: |
Active, not recruiting |
Study Name: AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma Condition:
Interventions: |
Completed |
Study Name: Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma Condition:
Interventions: |